StockData
Monopar Therapeutics logo

Monopar Therapeutics (MNPR) stock

MNPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$71.06−0.91 (-1.26%)

Close on Nov 17, 2026Market cap $476.97MP/E –Yield –

Monopar Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Monopar Therapeutics's market cap was $481.46M on Nov 11, 2026, against $574.21M a year earlier. Over the last 5 years it ranged from $4.12M to $751.29M, with a median of $38.93M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$481.46M+10.7%
2025Dec 31, 2025$435.09M+461.0%
2024Dec 31, 2024$77.55M+1505.5%
2023Dec 29, 2023$4.83M-84.1%
2022Dec 30, 2022$30.47M-24.6%
2021Dec 31, 2021$40.42M-42.3%
2020Dec 31, 2020$70.09M-54.6%
2019Dec 31, 2019$154.24M–

More Monopar Therapeutics figures

See a number that looks wrong?